Ipilimumab is a monoclonal antibody and immune checkpoint inhibitor that targets CTLA-4. It is widely used in research to study T-cell activation and tumor immunology, with applications in both in vitro assays and in vivo animal models of cancer.
Konzentration:
6.14 mg/mL
Molekulargewicht:
148 kDa
Reinheit:
99.60% (May vary between batches)
CAS Nummer:
[477202-00-9]
Target-Kategorie:
Immunology/Inflammation related,Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten